The patient with gastric adenocarcinoma had a tumor expressing programmed cell death-ligand 1 (PD-L1) and showing a fibroblast growth factor receptor 2 (FGFR2) amplification. This evidence concerns the gene CD274 and gastric adenocarcinoma.